OncoBriefs - Oncology Research News

May 02, 2026

Remission Is Not the End Credits

Remission Is Not the End Credits

Hodgkin lymphoma has one of the better reputations in cancer medicine, which sounds nice until you realize "better reputation" can hide a lot of mess. Cure rates are high. Treatments keep improving. Doctors have gotten much better at knocking the disease down. But this new Danish study asks the...

May 02, 2026

The Tumor Has a Vibe, Unfortunately

The Tumor Has a Vibe, Unfortunately

A quick translation. DNA methylation does not rewrite the genetic code. It acts more like editorial markup on top of it. Same script, different stage directions. In cancer, those stage directions can get weird fast.

May 02, 2026

The Verdict on the Androgen Receptor: Guilty, but the Defense Just Found a Loophole

The Verdict on the Androgen Receptor: Guilty, but the Defense Just Found a Loophole

The prosecution rested years ago. The androgen receptor (AR) was found guilty of driving prostate cancer - case closed, gavel down, everybody go home. Doctors threw the book at it with drugs like enzalutamide that clamp down on AR's ligand-binding domain like handcuffs on a suspect. But here's...

May 02, 2026

The scouting report on tired T cells

The scouting report on tired T cells

Your CD8 T cells are supposed to be the closer, the pass rush, the late-game assassin - pick your sport. They find infected or malignant cells, hit them hard, and keep the scoreboard moving in your favor. But when a fight drags on, those same cells can slide into T cell exhaustion, a state where...

May 02, 2026

When You Pull Weeds and Flowers Together, Everything Looks Like Dirt

When You Pull Weeds and Flowers Together, Everything Looks Like Dirt

A gardener who rips out every plant in the bed - roses and crabgrass alike - then concludes "nothing here was worth growing" hasn't really proven anything about roses. That, in a nutshell, is what three prominent Alzheimer's researchers just argued happened to the latest big-ticket review of...

May 02, 2026

When the Scan Lit Up the Room: JYP0322 Takes a Swing at ROS1's Nastiest Tricks

When the Scan Lit Up the Room: JYP0322 Takes a Swing at ROS1's Nastiest Tricks

The moment the first scan showed that a heavily pretreated ROS1-positive lung cancer had actually shrunk - and not just in the chest, but in the place doctors dread most, the brain - the researchers likely did what scientists do when they're internally screaming: they opened a spreadsheet and tried...

May 02, 2026

Your Body's Fat Is Helping Cancer Sneak Into Your Lungs - And a Diabetes Drug Might Stop It

Your Body's Fat Is Helping Cancer Sneak Into Your Lungs - And a Diabetes Drug Might Stop It

The smell of palmitic acid in a centrifuge tube is unremarkable - a faint, waxy nothing. It's the kind of molecule you'd walk right past in a lab without a second thought. But researchers at Nanjing University just caught this boring little fatty acid red-handed, running one of the most devious...

May 01, 2026

CDK Inhibitors: The Brakes, the Breakouts, and the Backup Plans

CDK Inhibitors: The Brakes, the Breakouts, and the Backup Plans

The problem with breast cancer's growth engine is that it does not just hit the gas - it studies the brake system, hires a locksmith, and comes back with a grudge. That is the world cyclin-dependent kinase, or CDK, inhibitors enter: a fight over whether cancer cells get to keep dividing like they...

May 01, 2026

MARCO Promotes Cholangiocarcinogenesis

MARCO Promotes Cholangiocarcinogenesis

Introducing MARCO: the immune receptor that helps tumors hide from your body's defenses - and the antibody that might shut it down.

May 01, 2026

Preventing Trogocytosis by Cathepsin B Inhibition Augments CAR T-Cell Function

Preventing Trogocytosis by Cathepsin B Inhibition Augments CAR T-Cell Function

Every great spy thriller has a mole - someone on the inside, passing secrets to the enemy, sabotaging missions from within. Your CAR T-cells, those genetically engineered assassins we send to hunt cancer, have been dealing with exactly this kind of double-agent problem. And a team of researchers...

May 01, 2026

Sexual Dimorphism of COVID-19 Inspires Drug Repositioning

Sexual Dimorphism of COVID-19 Inspires Drug Repositioning

Too much testosterone might kill you during COVID-19 - and too little testosterone might kill you just as fast.

May 01, 2026

When Spatial Transcriptomics Turns Into Group Chat Chaos

When Spatial Transcriptomics Turns Into Group Chat Chaos

Over 1,000 spatial transcriptomics samples were enough to inspire a 2025 practical guide, which is science-speak for: this field has officially outgrown the "cool demo" phase and entered the "please help, our data all speak different dialects" phase [6].

May 01, 2026

Your lungs are not just bellows with opinions

Your lungs are not just bellows with opinions

The review by Ofori-Amanfo, Dustin, and Lim looks at a fast-growing field where air pollution meets data science and lung health [1]. The basic idea is simple enough to explain over fries: pollution does not just irritate the lungs in a vague, hand-wavy way. It appears to nudge multiple biological...

April 30, 2026

Brain Metastases Are Not Empty Lots - They’re More Like Hidden Ruins With Armed Guards

Brain Metastases Are Not Empty Lots - They’re More Like Hidden Ruins With Armed Guards

Archaeologists spend years brushing dirt off one stubborn corner of the earth only to realize the "empty patch" was actually a city with plumbing, politics, and probably at least one guy skimming taxes. Brain metastases from breast cancer just got a similar plot twist. What looked like a barren...

April 30, 2026

One tumor, seven problems

One tumor, seven problems

DMG is a rare, aggressive brain tumor that usually strikes children and young adults. It tends to grow in the brainstem, thalamus, or spinal cord, which is a rotten place to have a tumor because those areas run the basics like movement, swallowing, and breathing. Surgery is often not realistic....

April 30, 2026

The Toxin Found the Doorbell

The Toxin Found the Doorbell

If E-cadherin is part of the Velcro that keeps neighboring epithelial cells attached, claudin-4 is part of the seal that helps keep the gut lining from turning into a leaky apartment building. The new paper shows that BFT does not just wander up and hack randomly at the wall like a raccoon with...

April 30, 2026

The Tumor’s Best Dirty Trick

The Tumor’s Best Dirty Trick

Pancreatic ductal adenocarcinoma is brutal partly because it gets very good at ignoring chemotherapy. One reason is something called epithelial-to-mesenchymal transition, or EMT. In normal biology, EMT helps cells become more mobile during development and wound repair. In cancer, it is more like a...

April 30, 2026

The brain is not taking walk-ins

The brain is not taking walk-ins

Breast cancer that spreads to the brain is one of oncology's meaner plot twists. It is dangerous, hard to treat, and loaded with biological nonsense that keeps grad students humble and antibodies unemployed. For years, brain metastases often got labeled "immune cold," which is science-speak for...

April 29, 2026

Prostate Cancer, Protein Stickers, and One Receptor That Refuses to Leave

Prostate Cancer, Protein Stickers, and One Receptor That Refuses to Leave

In Brisbane, where the river loops around the city like it has all the time in the world, a group of scientists went hunting for a very specific kind of cellular nonsense: why a prostate cancer protein called EphB4 hangs around longer than it probably should. And honestly, that is exactly the kind...

April 29, 2026

The Rash Was Never the Whole Story

The Rash Was Never the Whole Story

Mycosis fungoides, or MF, is the most common type of cutaneous T-cell lymphoma - a cancer of immune cells that prefers to loiter in the skin like it pays rent there [6,7]. It often behaves slowly, which sounds comforting until you remember that “slow” in cancer biology can also mean “sneaky enough...